Want to join the conversation?
On Sept. 9, 2015, $BIIB announced an agreement with Mitsubishi Tanabe Pharma Corp. (MTPC) to exclusively license MT-1303, a late stage experimental medicine with potential in multiple autoimmune indications. Under the terms of the agreement, $BIIB will receive worldwide rights to MT-1303, excluding Asia.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.